Chronically Active Lesions as a Trial Outcome in Multiple Sclerosis: A New Perspective on an Old Foe

Declan T Chard1

  • 1From the NMR Research Unit (D.T.C.), Queen Square MS Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London; and National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (D.T.C.), United Kingdom.

Neurology
|February 9, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos